The Searle Company Limited (PSX:SEARL)

Market Cap	52.90B +25.3%
Revenue (ttm)	35.99B +23.6%
Net Income	1.21B
EPS	2.06
Shares Out	588.22M
PE Ratio	24.52
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,967,986
Open	90.95
Previous Close	n/a
Day's Range	89.51 - 90.97
52-Week Range	66.96 - 137.44
Beta	0.48
Analysts	Buy
Price Target	104.35 (+16.02%)
Earnings Date	Oct 6, 2026

About The Searle Company

The Searle Company Limited, together with its subsidiaries, manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally. The company offers pharmaceutical products, such as analgesics and muscle relaxants, anti-allergy and anti-tussive, anti-anemic, anti-chelating, anti-infective, anti-neoplastic, anti-thrombotic, cardiovascular, endocrinology and metabolism, gastrointestinal, gynecology, urology and sex hormones, hepa...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1965
• Employees: 3,799
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: SEARL

Financial Performance

In fiscal year 2025, The Searle Company's revenue was 28.60 billion, a decrease of -2.72% compared to the previous year's 29.40 billion. Losses were -1.40 billion, -41.15% less than in 2024.